FDA Inspection
Jiangsu Anbison Pharmaceutical Co., Ltd.Jiangsu Anbison Pharmaceutical Co., Ltd. – FDA Inspection, Jul 16, 2024
Record Details
This FDA Inspection record concerns Jiangsu Anbison Pharmaceutical Co., Ltd., with an inspection on July 16, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · a3035420-47a3-4e76-9feb-4c3f8faa0583
Inspection Facts
- Inspection number
- 1246817
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Jiangsu Anbison Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for Jiangsu Anbison Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.